Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma

Carol L. Shields, MD; Lauren A. Dalvin, MD; Michael Chang, MD; Mehdi Mazloumi, MD, MPH; Patricia Fortin, BA; Mark McGarrey, BS; Andrei Martin, MD; Antonio Yaghy, MD; Xiaolu Yang, MD, Ph1; Pornpattana Vichitvejpaisal, MD; Arman Mashayekhi, MD; Jerry A. Shields, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756338

 

 

COMMENTARY:

Culver Boldt, MD; Timothy G. Murray, MD, MBA; Elaine M. Binkley, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756334

 

High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema

Khan M.A. · Mashayekhi A. · Ferguson K. · Shields J.A. · Shields C.L.

Read More

http://www.karger.com/Article/Abstract/448719